Swiss National Bank decreased its stake in shares of Balchem Co. (NASDAQ:BCPC – Get Rating) by 0.4% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 76,300 shares of the basic materials company’s stock after selling 300 shares during the period. Swiss National Bank’s holdings in Balchem were worth $9,899,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Pictet Asset Management SA increased its position in Balchem by 16.4% during the second quarter. Pictet Asset Management SA now owns 264,355 shares of the basic materials company’s stock worth $34,297,000 after purchasing an additional 37,173 shares during the last quarter. Lazard Asset Management LLC increased its position in Balchem by 4.6% during the second quarter. Lazard Asset Management LLC now owns 10,411 shares of the basic materials company’s stock worth $1,350,000 after purchasing an additional 458 shares during the last quarter. TownSquare Capital LLC acquired a new stake in shares of Balchem in the second quarter worth $234,000. Texas Permanent School Fund increased its position in shares of Balchem by 1.3% in the second quarter. Texas Permanent School Fund now owns 23,245 shares of the basic materials company’s stock worth $3,016,000 after acquiring an additional 288 shares in the last quarter. Finally, Zions Bancorporation N.A. increased its position in shares of Balchem by 22.3% in the second quarter. Zions Bancorporation N.A. now owns 6,788 shares of the basic materials company’s stock worth $881,000 after acquiring an additional 1,236 shares in the last quarter. Institutional investors and hedge funds own 89.15% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently issued reports on BCPC. HC Wainwright dropped their price objective on shares of Balchem from $164.00 to $152.00 and set a “buy” rating for the company in a research report on Monday, November 7th. StockNews.com began coverage on shares of Balchem in a research report on Wednesday, October 12th. They issued a “hold” rating for the company.
Balchem Price Performance
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
- Get a free copy of the StockNews.com research report on Balchem (BCPC)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.